This cheap vitamin may reduce the risk of cancer.

A recent study suggests that vitamin C consumption may reduce the likelihood of developing leukemia, potentially increasing patient survival rates. The research involved 109 participants diagnosed with clonal cytopenia of undetermined significance (CCUS) or myelodysplastic syndrome (MDS), conditions that can lead to acute myeloid leukemia. Participants were divided into two groups: one received 1000 mg of vitamin C daily, while the other took placebo tablets for a year. Over three years, those taking vitamin C showed a 65% lower mortality rate compared to the control group. This indicates that vitamin C supplementation could be a simple and cost-effective method to lower the risk of certain cancers, although further large-scale clinical trials are needed for conclusive evidence.